Related by context. All words. (Click for frequent words.) 68 ImmuKnow 66 Multiple logistic regression 66 Logistic regression 65 transient elastography 64 clinico pathological 64 PROCHYMAL 64 immunohistochemical analysis 64 Multivariate logistic regression 63 immunohistochemical 63 troponins 63 PD2i ® 63 GAMMAGARD 63 Carotid Revascularization Endarterectomy vs. 63 retrospective cohort 63 Kaplan Meier analysis 63 KRAS mutation 63 ToGA 63 carotid artery stenting 63 ADAGIO study 63 RE LY trial 63 prospective multicentre 63 eTag assays 62 STRIDE PD 62 conditional logistic regression 62 BEXXAR Therapeutic Regimen 62 AtherOx 62 Echocardiographic 62 Kaplan Meier method 62 MTT assay 62 transcranial Doppler ultrasound 62 ADVEXIN therapy 62 KRAS status 62 pancreatic adenocarcinoma 62 RECIST Response Evaluation Criteria 62 multivariate logistic regression 62 myocardial viability 62 prospective multicenter study 61 Logistic regression analysis 61 acetabular fractures 61 florbetaben 61 metastatic neuroendocrine tumors 61 AlloMap 61 renal biopsy 61 ACUITY trial 61 riociguat 61 bladder augmentation 61 etiologic 61 prognostic markers 61 urothelial cancer 61 MDRD equation 61 phase IIIb 61 GRNCM1 61 multivariate regression analysis 61 uricase 61 FDG PET 61 VerifyNow P#Y# 61 MAGE A3 ASCI 61 EBUS FNA 61 Lp PLA 2 61 Multivariate analysis 61 PLX cells 61 liver transplant recipients 61 ImmuKnow R 61 contrast echocardiography 61 Subgroup analyzes 61 glomerular filtration 61 Vascugel 60 pain palliation 60 Corus CAD 60 PLAC test 60 LV dysfunction 60 p# biomarker 60 magnetic resonance spectroscopy MRS 60 stratifying patients 60 logistic regression models 60 adipose derived stem cells 60 gastric adenocarcinoma 60 S. maltophilia 60 Aprotinin 60 prognostic significance 60 LVNC 60 nomogram 60 Observational studies 60 Framingham Risk Score 60 CTEPH 60 QTc prolongation 60 allogeneic HSCT 60 oncologic outcomes 60 intracranial stenosis 60 MTWA testing 60 VerifyNow 60 logistic regression analysis 60 MDRD 60 recurrent glioblastoma multiforme 60 Adult Stem Cell Therapy 60 rFVIIa 60 thromboembolic disease 60 Non inferiority 60 HIV tropism 60 CALGB 60 genomic biomarker 60 FDG PET imaging 60 OPCAB 60 EchoCRT 60 Lp PLA2 60 angiographically 60 RE LY ® 60 Oncotype DX Recurrence Score 60 HCV SPRINT 60 cardiac troponin T 60 differential gene expression 60 #F FDG PET 60 Capsule endoscopy 60 transcranial Doppler 60 prognostic indicator 60 HSCT 60 AlloMap testing 60 Coronary artery bypass grafting 60 pharmacodynamic parameters 60 CMV reactivation 60 Cardiorespiratory fitness 60 estimated GFR 60 IPAH 60 masitinib 60 preoperative MRI 60 PD2i R 60 CSF biomarkers 60 AGHD 59 Hepatocellular Carcinoma HCC 59 Subgroup analysis 59 PNH patients 59 HER2 expression 59 antioxidant supplementation 59 haemodynamic 59 OptiVol 59 CP CPPS 59 Intervention Trial GAIT 59 Multiple linear regression 59 ConclusionThis 59 logistic regression analyzes 59 acute humoral rejection 59 NATRECOR ® 59 preclinically 59 prospective nonrandomized 59 hepatorenal syndrome 59 sirolimus eluting stents 59 subgroup analyzes 59 sorafenib Nexavar 59 PITX2 methylation 59 ischemic cardiomyopathy 59 renal tumors 59 intact parathyroid hormone 59 anti angiogenic therapy 59 CardioFit 59 poor metabolizers 59 differentiate squamous 59 ReN# 59 clinicopathological 59 engineered urethras 59 ximelagatran 59 EUS FNA 59 hemostatic efficacy 59 Cardiotoxicity 59 bronchopulmonary dysplasia BPD 59 PROactive study 59 xCELLigence System 59 Eculizumab 59 DNA methylation markers 59 Stenting Trial CREST 59 Liver biopsy 59 ADPKD 59 skin sterol 59 bone scintigraphy 59 serum biomarkers 59 BARI 2D 59 multicenter trials 59 pharmacodynamic effects 59 multivariable logistic regression 59 prognostic indicators 59 sipuleucel T 59 surrogate markers 59 F FDG PET 59 prospectively defined 59 histological subtype 59 meta regression 59 K ras mutations 59 neoadjuvant therapy 59 hypervascular tumors 59 depsipeptide 59 antiangiogenic therapy 59 Aethlon Hemopurifier R 59 multicenter randomized clinical 59 immunochemical fecal occult 59 EuroSCORE 59 unresectable tumors 59 allogeneic stem cell 59 surrogate endpoint 59 Histological 59 osteoporotic compression fractures 59 Doxil ® 59 carotid artery stenting CAS 59 prognostic variables 59 NICE SUGAR 59 allogeneic bone marrow 58 multiple logistic regression 58 pharmacologic stress 58 miRview mets 58 Cystatin C 58 conventional angiography 58 TAXUS ARRIVE 58 multivariable analysis 58 hematopoietic cancers 58 DEXA scan 58 EquiTrend ® 58 Trandolapril 58 mycophenolate mofetil 58 chronic myocardial ischemia 58 carotid plaque 58 miRview squamous 58 colorectal liver metastases 58 extramedullary 58 Vectibix monotherapy 58 ASPIRE HIGHER 58 Histologic 58 transesophageal echocardiography 58 adjuvant therapies 58 RQ PCR 58 multicenter randomized controlled 58 spirometric 58 Cardiopulmonary bypass 58 relapsed MM 58 HoFH 58 histologic findings 58 Acute Myocardial Infarction AMI 58 liver biopsies 58 cystatin C 58 FDG PET CT 58 PROLARIS 58 EMPHASIS HF trial 58 prognostic marker 58 APOE genotype 58 gefitinib Iressa 58 ExTRACT TIMI 58 chemosensitivity 58 EGFR HER2 58 AA Amyloidosis 58 Haptoglobin 58 hip resurfacing arthroplasty 58 diabetes mellitus DM 58 pretargeting 58 Response Evaluation Criteria 58 Immunohistochemistry 58 Natalizumab 58 PREVENT IV 58 hemodialysis patients 58 Poisson regression 58 prostate cancer CaP 58 fosbretabulin 58 fluvastatin 58 longitudinal cohort study 58 MGd 58 EXJADE 58 Coronary CTA 58 NMIBC 58 diagnostic modality 58 MitraClip device 58 Certican 58 AST ALT 58 Patient Registry 58 cerebral oximetry 58 plasma pharmacokinetics 58 clevidipine 58 TAXUS Stent 58 randomized multicenter trial 58 percutaneous vertebroplasty 58 metabolomic profiling 58 PFO migraine 58 renal denervation 58 atherogenic dyslipidemia 58 recurrent glioma 58 Dialysis Outcomes 58 StemEx R 58 LEUKINE 58 Screening Trial 58 hepatectomy 58 SYNTAX trial 58 histopathologic findings 58 renal transplantation 58 Digital Mammographic Imaging 58 MammaPrint R 58 microRNA profiling 58 pretransplant 58 Xanafide 58 urothelial carcinoma 58 multicenter Phase II 58 prospective longitudinal 58 FDG-PET/CT 58 Bifantis 58 hemodynamic variables 58 retrospective observational study 58 Clinical Relevance 58 Regression analyzes 58 percutaneous cryoablation 58 Velcade bortezomib 58 transthoracic 58 hematological parameters 58 Deforolimus 58 CaPSURE 58 carotid stenosis 58 conventional coronary angiography 58 Meta analyzes 58 nomograms 58 Trofex 58 graft dysfunction 58 endometrial hyperplasia 58 differentially expressed genes 57 HDL Selective Delipidation 57 prospective observational cohort 57 chest radiographs 57 interobserver reliability 57 HeartNet 57 Dr. Fehlings 57 miRview ™ squamous 57 cediranib 57 NOD SCID mice 57 pharmacokinetic PK study 57 sCD# 57 intraobserver 57 Teriflunomide 57 RRM1 57 Descriptive statistics 57 chemoprevention trials 57 YONDELIS 57 prostate cancer PCa 57 allogeneic hematopoietic stem cell 57 multicenter clinical 57 endoscopic ultrasonography 57 Renal Cell Carcinoma RCC 57 ICD implantation 57 superficial bladder cancer 57 HOMA IR 57 IMPROVE HF 57 pCR 57 Allogeneic 57 chronic granulomatous disease 57 CIMZIA TM certolizumab pegol 57 INTERCEPT platelets 57 histopathologic 57 STICH trial 57 renal scarring 57 recurrent GBM 57 antiplatelet therapies 57 ENESTnd 57 postoperative pulmonary 57 tissue oxygenation 57 resected pancreatic cancer 57 Venous thromboembolism 57 inhaled cyclosporine 57 transplantation HSCT 57 microRNA expression 57 bioartificial liver 57 cytoreductive nephrectomy 57 FibroScan ® 57 randomized controlled trials RCTs 57 Infarct 57 transcriptional profiling 57 renal allograft 57 Masimo PVI 57 prostate carcinoma 57 INTERHEART 57 strontium ranelate 57 haematopoietic 57 percutaneous transluminal coronary angioplasty 57 Traficet EN 57 kidney transplant recipients 57 Dr. Grekos 57 BENICAR HCT 57 plerixafor 57 fluorescein angiography 57 microRNA biomarkers 57 antiangiogenic agent 57 Regression analysis 57 electrophysiologic 57 Phase IIIb study 57 albumin excretion rate 57 Acute Decompensated Heart Failure 57 thoracoscopic lobectomy 57 transesophageal echocardiography TEE 57 liver resection 57 SCD HeFT 57 ELISPOT 57 PCI ExTRACT TIMI 57 pressor response 57 invasive aspergillosis 57 pharmacokinetic characteristics 57 allogeneic transplant 57 gauge vitrectomy 57 troponin T 57 thalidomide Thalomid 57 MRgFUS 57 ELBW infants 57 HERmark 57 MERLIN TIMI 57 Anticalins ® 57 Hepatotoxicity 57 tumor histology 57 RE LY 57 BERKELEY CA UroToday.com 57 plasma renin activity 57 ALTTO 57 bowel capsule endoscopy 57 radioiodine therapy 57 pre operatively 57 urine NGAL 57 FinESS 57 MammaPrint ® 57 gastrointestinal stromal tumors GIST 57 HIF PH inhibitors 57 elacytarabine 57 APTIMA HPV 57 stem cell transplantations 57 Onconase 57 biopsied tissue 57 vismodegib 57 NeuroStar TMS Therapy 57 immunosuppressive regimen 57 pharmacogenetic testing 57 ALA PDT 57 terlipressin 57 Severe Asthma 57 Randomized trials 57 atherothrombotic disease 57 perfusion MRI 57 bronchoalveolar lavage 57 ABL1 57 Pertuzumab 57 hsCRP levels 57 HER2 overexpression 57 SEER database 57 vildagliptin 57 Ovarian PLCO Cancer 57 favorable pharmacokinetic profile 57 CIN2 + 57 β blockers 57 Insulin Delivery Systems 57 optical coherence tomography OCT 57 Aspergillus nidulans 57 angiographic outcomes 57 KIF6 gene variant 57 renal transplants 57 lactate dehydrogenase LDH 57 cervical carcinoma 57 urolithiasis 57 Sentinel Lymph Node Biopsy 57 EGFR mutation status 57 SYNTAX 57 perioperative mortality 57 CYPHER R Sirolimus eluting 57 Lipid Lowering Treatment 57 intracranial hemorrhage ICH 57 delafloxacin 57 hESC derived cardiomyocytes 57 abdominal adiposity 57 seropositivity 57 glycated hemoglobin levels 57 vProtect TM Luminal Shield 57 airway hyperresponsiveness 57 candidemia 57 Symadex 56 colorectal adenoma 56 mesenchymal stem cells MSCs 56 Kaplan Meier curve 56 metabolomic profiles 56 myocardial revascularization 56 kidney urologic 56 cardiac resynchronisation therapy 56 mRCC 56 autologous SCT 56 Solorel TM 56 BACcel ™ system 56 Pemphigus 56 perioperative complications 56 cytogenic 56 aldosterone antagonist 56 Fully Covered Stent 56 prospectively stratified 56 chromium supplementation 56 MYTHOS trial 56 myeloproliferative 56 everolimus eluting stents 56 angiography CTA 56 immunosuppressive therapies 56 eNO 56 echocardiographic 56 DMIST 56 relapsed ALL 56 myeloperoxidase 56 UroVysion 56 NAVISTAR R 56 Warfarin Coumadin 56 inflammatory biomarkers 56 cinacalcet 56 Nesiritide 56 Epidemiologic studies 56 Vascular Wrap 56 TACI Ig 56 Tumor Response 56 APPRAISE 56 CellPort Technologies 56 perfusion abnormalities 56 randomized blinded 56 Intervention Effectiveness 56 engineered RAP peptides 56 Ejection Fraction 56 INVEGA ® 56 Corgentin 56 plasma creatinine 56 Advanced Heart Failure 56 K DOQI 56 nonrandomized 56 ASCUS 56 vidofludimus 56 chemoembolization 56 univariate analyzes 56 Gleevec resistant 56 GnRH agonists 56 flavopiridol 56 liver metastasis 56 VKORC1 56 ONTARGET 56 rEEG 56 FCGR3A 56 multivariate analyzes 56 PRECISE 56 plasminogen activators 56 COR Analyzer 56 osteoid osteoma 56 HoLEP 56 Cardiac Allograft Rejection 56 ORENCIA R 56 SSc 56 Lymph node 56 Zevalin consolidation 56 angiography CCTA 56 glomerular filtration rate 56 TAXUS Liberte Stent 56 multivariate Cox 56 ICD therapy 56 AIM HIGH 56 cardiac perfusion 56 Vasogen Celacade 56 multiple linear regression 56 platelet reactivity 56 NYHA functional class 56 transurethral resection 56 hematologic parameters 56 observational cohort study 56 cTnI 56 Microalbuminuria 56 cardiac dysfunction 56 randomized multicenter Phase III 56 AVERROES 56 nesiritide 56 Treatment Outcome 56 refractory angina 56 Phase IIB 56 myogenic cell 56 ZACTIMA 56 echocardiographic parameters 56 sunitinib Sutent 56 NSABP B 56 leukocyte count 56 Azedra 56 pharmacokinetic PK 56 metastatic malignant 56 metabolic parameters 56 GORE TAG Device 56 cardiac troponin 56 genetic polymorphisms 56 Amplimexon 56 Computed tomographic 56 PLCO 56 retrospective cohort study 56 carotid angioplasty 56 #m Tc 56 biostatistical analysis 56 bivariate analysis 56 Registry NOPR 56 allogeneic transplants 56 debulking surgery 56 TLE3 56 palliative radiotherapy 56 GIST tumors 56 serum GGT 56 viral kinetics 56 Univariate 56 adolescent idiopathic scoliosis 56 NGAL 56 proteomic analysis 56 TACE 56 MGUS 56 serum leptin 56 Stenting Trial 56 novel oral anticoagulant 56 T SPOT.TB 56 cerebral vasospasm 56 fluorodeoxyglucose positron emission tomography 56 pharmacodynamic PD 56 follicular lymphomas 56 TNM staging 56 advanced neoplasia 56 ACZ# 56 adult mesenchymal stem 56 genotypic resistance 56 Surgical resection 56 adenoma recurrence 56 qRT PCR 56 cytoreductive surgery 56 diagnostic biomarker 56 ELISpot 56 TLR antagonist 56 EGFR inhibition 56 biochemical recurrence 56 serum phosphate 56 NSQIP 56 intravesical therapy 56 CMV disease 56 ON #.Na 56 pertuzumab 56 CMV infection 56 Liver transplantation 56 STEEN Solution ™ 56 azacitidine 56 transthoracic echocardiography 56 persistent pulmonary hypertension 56 mertansine 56 BCR ABL mutations 56 Mutation Analysis 56 pharmacokinetic parameters 56 VTE prophylaxis 56 prospective randomized controlled 56 Skin sterol 56 SpCO 56 corneal ectasia 56 Carotid endarterectomy 56 NEVO ™ 56 PSA nadir 56 Catena ® 56 multicentre prospective 56 epidural steroid injection 56 HeFT 56 myocardial perfusion 56 symptomatic VTE 56 ICAEL 56 specific antigen PSA 56 induced sputum 56 LipiScan 56 morphometric vertebral fractures 56 thoracic aortic aneurysms 56 Ag Ab Combo 56 perioperative morbidity 56 biomarker assay 56 Solid Tumors 56 chronic thromboembolic pulmonary 56 eosinophilic pneumonia 56 hematopoietic cell 56 cardiac allograft vasculopathy 56 siRNA knockdown 56 kidney allograft 56 univariate 56 Computed Tomographic 56 GEM OS1 56 K ras mutation 56 thyroglobulin 56 optical coherence tomography 56 ADCS CGIC 56 Mr. Fater 56 spiral computed tomography 56 Pamidronate 56 hyperplastic 56 trastuzumab DM1 T DM1 56 diagnostic angiography 56 micrometastasis 56 paricalcitol 56 central corneal thickness 56 baseline LDH 56 MabCampath 56 eprotirome 56 carotid IMT 56 follicular adenoma 56 haematopoietic stem cell 56 methylation markers 56 IL# PE#QQR 56 cranial irradiation 56 adenomatous 56 cartilage regeneration 56 perfusion defect 56 BCIRG 56 neratinib 56 BODE index 56 ARIXTRA 56 Phase IIIb clinical 56 transcatheter aortic valve implantation 56 ADHERE 56 ertapenem 56 MADIT II 56 CYP#C# [001] 55 CBLC# 55 STEP BD 55 efficacy evaluable 55 Solid Tumors RECIST 55 Triolex 55 mesenchymal stem cell 55 CALGB # [002] 55 XmAb# 55 prostate TURP 55 Outpatient Setting 55 serum biomarker 55 Renal dysfunction 55 antithrombotic therapy 55 R0 resection 55 Daxor 55 Reynolds Risk Score 55 antibody mediated 55 carotid stenting 55 nonpharmacologic 55 Mammostrat 55 sunitinib 55 GRAVITAS trial 55 co receptor tropism 55 Radical prostatectomy 55 Clinical Antipsychotic Trials 55 fluorescent microscope 55 molecular biomarkers 55 transvaginal sonography 55 BioMAP ® 55 ACS NSQIP 55 GPx 55 Islet transplantation 55 galiximab 55 HORIZONS AMI trial 55 SYNTAX Score 55 IQWiG 55 nonalcoholic steatohepatitis 55 vertebral compression fractures 55 samalizumab 55 pathologic examination 55 Carticel 55 microalbuminuria 55 Histopathological 55 briakinumab 55 NMP# assay 55 thrombotic complications 55 immunohistochemistry IHC 55 noninvasive technique 55 phase IIa clinical 55 Thrombolysis 55 NATRECOR R 55 duplex ultrasonography 55 antigen PSA levels 55 immunohistochemical staining 55 colorectal carcinoma 55 localized prostate 55 Fractional Flow Reserve 55 pharmacodynamic markers 55 immunosuppressive regimens 55 intracoronary 55 intravascular ultrasound 55 miRNA expression 55 ECD kidneys 55 Septin 9 55 Neuradiab 55 surrogate marker 55 coinfected patients 55 OLYMPIA registry 55 molecular biomarker 55 postoperative atrial fibrillation 55 Ebstein anomaly 55 bypass grafting 55 silent ischemia 55 Hypotension 55 predictive validity 55 Tasigna prolongs 55 transcatheter closure 55 bioprosthetic valve 55 CT coronary angiography 55 Prospective Randomized 55 radioligand 55 transcranial magnetic stimulation TMS 55 allogeneic hematopoietic cell 55 intraoperative complications 55 Univariate analysis 55 Confocal microscopy 55 PITX2 55 cardioembolic stroke 55 therapeutic regimens 55 bile acid metabolism 55 noninvasive imaging 55 convergent validity 55 refractory CLL 55 XIENCE V PROMUS Stent 55 RECIST 55 ACOSOG Z# 55 SYNERGY Stent 55 IRX 2 55 Cytogenetic 55 LUMINATE 55 Multivariable logistic regression 55 residual confounding 55 PRTX 55 multicentre randomized 55 postoperative complication 55 LNG IUS 55 ULORIC 55 thickness CIMT 55 cardiac computed tomography 55 physiologic parameters 55 thorough QT 55 Magnetic resonance 55 OncoVEX 55 hematopoietic cells 55 placebo controlled clinical 55 sargramostim 55 renal cell carcinomas 55 Bucindolol 55 prospectively randomized 55 retrospectively analyzed 55 Dr Chavarro 55 elective PCI 55 miRview TM mets 55 Octreolin 55 Li Fraumeni Syndrome 55 SLN biopsy 55 Angiox R 55 defibrillator implant 55 ruboxistaurin 55 Clinicaltrials.gov 55 cortical stimulation 55 randomizing patients 55 metastatic renal cell carcinoma 55 serum antibody 55 Western blotting 55 infarcted myocardium 55 logistic regression model 55 CINtec ® PLUS 55 trastuzumab emtansine T DM1 55 Umbilical cord stem cells 55 XIENCE V Everolimus Eluting 55 NOD mouse 55 iPTH 55 Bonferroni correction 55 ALTROPANE 55 transrectal ultrasound guided 55 ROCKET AF 55 radiographic outcomes 55 Estrogen Receptor 55 TIMP 1 55 DAS# CRP 55 circulating EPCs 55 APTIVUS r 55 Ceplene/IL-2 55 oral anticoagulation 55 BACcel 55 monogenic 55 miRview ™ mets 55 Augment Injectable Bone Graft 55 C Reactive Protein 55 lung resection 55 Acute Coronary Syndromes 55 carotid artery stenosis 55 adenotonsillectomy 55 Acute Ischemic Stroke 55 eculizumab therapy 55 HCV RESPOND 2 55 Postoperative complications 55 LDLT 55 postmenopausal osteoporotic women 55 thrombocytopenic 55 BioMAP 55 TMPRSS2 ERG fusion 55 decitabine 55 CA9 SCAN 55 Langerhans cell histiocytosis 55 histologic diagnosis 55 ACI TIPI 55 leiomyomas 55 coronary stenosis 55 Prostate Lung Colorectal 55 busulfan 55 metastatic RCC 55 varespladib 55 nonrandomized studies 55 AFRS TM 55 scintigraphic 55 macrovascular disease 55 Ovarian Cancer Screening 55 topical NSAIDs 55 HeFH 55 Angiographic 55 RIO Lipids 55 ELCAP 55 EBMT criteria 55 varicoceles 55 unstable angina pectoris 55 androgen deprivation 55 secretin 55 PCA3 55 bone marrow mononuclear cells 55 haematologic 55 procalcitonin 55 sustained virological response 55 Cellvizio R 55 testosterone supplementation 55 fibrotic disease 55 AIR2 Trial 55 circulating endothelial cells 55 plasma kallikrein inhibitor 55 serum urate levels 55 Onrigin 55 OncoVEX GM CSF 55 immunostaining 55 percutaneous aortic valve 55 autonomic dysfunction 55 PRECISE trial 55 Rheumatologists 55 Afatinib 55 Optical Coherence Tomography 55 electron beam computed tomography 55 oncological outcomes 55 Brodmann Area 55 bardoxolone methyl 55 ANCOVA 55 cells hESCs 55 hepatocellular carcinoma 55 microarray analysis 55 serum lipid levels 55 solithromycin 55 postoperative mortality 55 pancreatic ductal adenocarcinoma 55 lipoprotein levels 55 multivariable Cox 55 intravascular ultrasonography 55 myelofibrosis polycythemia vera 55 concurrent chemoradiation 55 Reveal XT 55 olaparib 55 Mantel Haenszel 55 CT Angiography 55 Hyperlipidemia 55 Coronary artery bypass 55 gene expression profiling 55 decompensated heart failure 55 DHEA supplementation 55 DSM IV diagnoses 55 Endo PAT 55 myocardial ischaemia 55 BRAF V#E mutation 55 transplanted islets 55 mononuclear cells 55 bladder carcinoma 55 recurrent miscarriage 55 non squamous NSCLC 55 CHAMPION PLATFORM 55 Afib 55 Ischemic 55 pancreatectomy 55 Pulse oximetry 55 TAXUS TM 55 HGPIN 55 Uncontrolled hypertension 55 virotherapy 55 ACTEMRA TM 55 velafermin 55 EDEMA3 55 intraventricular 55 CARE HF 55 Hematopoietic 55 PROMUS R 55 actigraphy 55 CT colonography CTC 55 CCX# 55 elevated CRP 55 FOLFIRINOX 55 obstructive coronary artery 55 #F FDG 55 INTERCEPT treated 55 Dr. Ayalew Tefferi 55 functional neuroimaging 55 PON1 activity 55 plain radiographs 55 Severe Sepsis 55 Advagraf 55 plasma lipid 55 Doppler echocardiography 54 CHAMPION PCI 54 periprocedural MI 54 TPMT 54 pericardial effusion 54 Kantarjian